相关实验视频

Updated: Aug 9, 2026

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

截断的PDGFRB的促进者交换驱动Ph类急性淋巴细胞白血病

Bunpei Miyazaki¹, Toshihide Ueno², Masanaka Sugiyama¹

¹Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.

NPJ precision oncology

|December 9, 2023

概括

在费城染色体样急性淋巴细胞白血病 (Ph-like ALL) 中,发现了一种新的NRIP1::PDGFRB融合基因. 这种融合驱动瘤发生,并被ABL1激酶抑制剂有效抑制.

科学领域:

血液学血液学血液学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

费城染色体样急性淋巴细胞白血病 (Ph样ALL) 与治疗结果不佳有关.
PDGFRB基因融合是Ph类ALL的常见标志,通常涉及增强激酶活性的二元化域.

研究的目的:

为了识别和表征新型瘤性PDGFRB融合基因在Ph类ALL.
调查发现的融合的致癌潜力和治疗脆弱性.

主要方法:

在小儿ALL患者中发现了一种新型NRIP1::PDGFRB融合基因.
在体外证实NRIP1::PDGFRB.的致癌潜力.
评估多代ABL1特异性氨酸激酶抑制剂的疗效.

主要成果:

发现了一种新型的融合基因NRIP1::PDGFRB,它编码了PDGFRB的激酶域,没有伴侣.
NRIP1::PDGFRB在体外表现出致癌潜力.
所有测试的ABL1抑制剂 (imatinib,dasatinib,nilotinib,ponatinib) 都有效地抑制了NRIP1::PDGFRB.的致癌潜力.

结论:

确定了Ph类ALL的一个新型融合基因模式.
该NRIP1::PDGFRB融合代表了一个新的可向的驱动器在Ph类ALL.
准ABL1激酶是一种可行的治疗策略,用于含有这种融合的Ph样ALL.

更多相关视频

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

相关概念视频

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...